| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_addeacd052e5d2fe9286b37ced807f46 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7092
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00 |
| filingDate |
2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7679d010096dcabbb2e98e6302ed5ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73443467dbca95444ee538b3de7970f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b7f44c360144cba4bbdb8f2841c189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b9462a12582481e5039bbe6f87f537f |
| publicationDate |
2009-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2356580-C2 |
| titleOfInvention |
Compositions and methods providing controlled drug loss and delivery within transdermal drug delivery systems |
| abstract |
FIELD: medicine. ^ SUBSTANCE: invention refers to medicine. There is disclosed local transdermal delivery system of one or several active agents contained in one and/or several layers of polymer and/or adhesive carrier directly adjoining a polymer and/or adhesive coating not containing a drug applied either on a base, or on a separating filler of transdermal system. ^ EFFECT: transdermal delivery tool is made by optimising drug charge combined with required adhesion to skin or mucous membrane, and ensures possibility of drug delivery modulation and its profile. ^ 21 cl, 5 dwg, 3 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2627869-C2 |
| priorityDate |
2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |